.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Ovis has shown a consistent presence in the Alberta market within the Capsules category, maintaining a steady ranking among the top 10 brands. Starting the year at 9th place in both January and February 2025, Ovis improved its position to 7th place in March, before slightly dipping to 8th in April. This fluctuation suggests a competitive landscape in Alberta's Capsules category, with Ovis managing to keep a strong foothold despite the challenges. The sales data indicates a notable trend where March saw a resurgence in sales after a dip in February, highlighting potential seasonal or promotional impacts that might have influenced consumer behavior.
While Ovis has managed to stay within the top 10 in Alberta's Capsules category, it's important to note that their absence from the top 30 in other states and categories could be seen as an area for potential growth or a challenge in expanding their market presence. The lack of ranking in other regions might suggest that Ovis is either focusing its efforts predominantly in Alberta or facing stiff competition elsewhere. For stakeholders and followers of the brand, this could be a point of interest in terms of strategizing for broader market penetration or identifying key factors that contribute to their success in Alberta.
Competitive Landscape
In the Alberta capsules market, Ovis has demonstrated a noteworthy upward trajectory in its ranking, moving from 9th place in January 2025 to 7th in March before settling at 8th in April. This positive trend indicates a strengthening position amidst a competitive landscape. Notably, Emprise Canada consistently maintained a higher rank, although its sales showed a declining trend from January to April. Meanwhile, Frank also remained ahead of Ovis, but its sales experienced fluctuations, suggesting potential vulnerabilities. Dosecann and Portals both exhibited lower rankings and sales figures compared to Ovis, with Portals even dropping out of the top 20 in April. These dynamics highlight Ovis's potential to capitalize on its upward momentum and capture more market share from competitors experiencing sales declines or rank instability.
Notable Products
In April 2025, the top-performing product from Ovis was the Blue THC Softgel 15-Pack (150mg), maintaining its consistent number one ranking from previous months with a sales figure of 1284 units. The CBG/CBD/THC 1:1:1 Softgels 15-Pack (75mg CBG, 75mg CBD, 75mg THC) climbed to the second position, showing a slight improvement from third place in March. The Blue THC Softgel 50-Pack (125mg) ranked third, dropping from its second-place position in March. The CBD:THC 50:5 Softgels 15-Pack (750mg CBD, 75mg THC) remained steady at fourth place, while the CBN Goftgels 10-Pack (200mg CBN) also held its fourth-place position from March. Overall, the rankings indicate a stable performance for Ovis products with minimal shifts in their standings.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
